Basic information Supplier
Spiro[5,7-etheno-1H,11H-cyclobut[i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-2(3H),1′(2′H)-naphthalen]-8(9H)-one, 6′-chloro-3′,4′,12,13,16,16a,17,18,18a,19-decahydro-16-methoxy-11,12-dimethyl-16-[[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methyl]-, 10,10-dioxide, (1′S,11R,12S,14E,16R,16aR,18aR)- Structure

Spiro[5,7-etheno-1H,11H-cyclobut[i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-2(3H),1′(2′H)-naphthalen]-8(9H)-one, 6′-chloro-3′,4′,12,13,16,16a,17,18,18a,19-decahydro-16-methoxy-11,12-dimethyl-16-[[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methyl]-, 10,10-dioxide, (1′S,11R,12S,14E,16R,16aR,18aR)-

Chemical Properties

Density  1.31±0.1 g/cm3(Predicted)
storage temp.  Store at -20°C
form  Solid
pka 8.21±0.20(Predicted)
color  White to off-white
FDA UNII BO0V7196L2

Preparation Products And Raw materials

Spiro[5,7-etheno-1H,11H-cyclobut[i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-2(3H),1′(2′H)-naphthalen]-8(9H)-one, 6′-chloro-3′,4′,12,13,16,16a,17,18,18a,19-decahydro-16-methoxy-11,12-dimethyl-16-[[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methyl]-, 10,10-dioxide, (1′S,11R,12S,14E,16R,16aR,18aR)- Suppliers